Prevalence of chronic kidney disease and associated risk factors, and risk of end-stage renal disease: Data from the PREVADIAB study

Nephron - Clinical Practice

Volumn 119, Issue 1, 2011, Pages

  Vinhas, José ^a   Gardete Correia, Luis ^b   Boavida, José Manuel ^c   Raposo, João Filipe ^b   Mesquita, Ana ^b   Fona, Maria Conceição ^b   Carvalho, Raquel ^b   Massano Cardoso, Salvador ^d  

^a Centro Hospitalar de Setubal   (Portugal)

^b Portuguese Diabetes Association   (Portugal)

^c General Directorate of Health   (Portugal)

^d Department of Epidemiology   (Portugal)

Author keywords

Chronic kidney disease; End stage renal disease; PREVADIAB study

Indexed keywords

CREATININE; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; CHOLESTEROL BLOOD LEVEL; CHRONIC KIDNEY DISEASE; COMPARATIVE STUDY; CREATININE BLOOD LEVEL; DIABETES MELLITUS; DIET RESTRICTION; DISEASE COURSE; EUROPE; FEMALE; GLOMERULUS FILTRATION RATE; GLUCOSE BLOOD LEVEL; HEALTH SURVEY; HUMAN; INCIDENCE; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; OBESITY; ORAL GLUCOSE TOLERANCE TEST; PORTUGAL; PREVALENCE; PRIORITY JOURNAL; QUESTIONNAIRE; RISK FACTOR; TRIACYLGLYCEROL BLOOD LEVEL; UNITED STATES;

ADULT; AGED; DIABETES MELLITUS; DISEASE PROGRESSION; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY; PORTUGAL; PREVALENCE; QUESTIONNAIRES; RISK FACTORS; YOUNG ADULT;

EID: 79957954284     PISSN: None     EISSN: 16602110     Source Type: Journal    
DOI: 10.1159/000324218     Document Type: Article

References (35)

1. Schoolwerth AC, Engelgau MM, Hostetter TH, et al: Chronic kidney disease: A public heath problem that needs a public health action plan. Prev Chronic Dis 2006; http:// www.cdc.gov/pcd/issues/2006/apr/05-0105. htm.
2. Zhang Q-L, Rothenbacher D: Prevalence of chronic kidney disease in population-based studies: Systematic review. BMC Public Health 2008; 8: 117-129.
3. PRTESRD - Portuguese Registry on the Treatment of ESRD. http://www.spnefro.pt/ comissoes-gabinetes/Gabinete-registo-2008/default.asp.
4. DuBose TD: American Society of Nephrology Presidential Address 2006: Chronic kidney disease as a public health threat - new strategy for a growing problem. J Am Soc Nephrol 2007; 18: 1038-1045.
5. US Renal Data System. USRDS 2007 annual data report: Atlas of end-stage renal disease in the United States, National Institutes of Health, Minneapolis. http://www.usrds.org/ adr.htm.
6. Gardete-Correia L, Boavida JM, Raposo JF, Mesquita AC, Fona C, Carvalho R, Massano- Cardoso S: First diabetes prevalence study in Portugal: PREVADIAB study. Diabet Med 2010; 27: 879-881.
7. IDF Worldwide Definition of the Metabolic Syndrome. http://www.idf.org/ metabolic-syndrome.
8. Lamb EJ, Tomson CRV, Roderick PJ: Estimating kidney function in adults using formulae. Ann Clin Biochem 2005; 42: 321-345. (Pubitemid 41354394)
9. K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification. Kidney Disease Outcome Quality Initiative. Am J Kidney Dis 2002; 39:S1-S246.
10. Coresh J, Astor BC, Greene T, Eknoyan G, Levey AS: Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis 2003; 41: 1-12. (Pubitemid 36043346)
11. Viktorsdottir O, Palsson R, Andresdottir MB, Aspellund T, Gudnason V, Indridason OS: Prevalence of chronic kidney disease based on estimated glomerular filtration rate and proteinuria in Icelandic adults. Nephrol Dial Transplant 2005; 20: 1799-1807. (Pubitemid 41222591)
12. Hallan SI, Coresh JC, Astor BC, et al: International comparison of the relationship of chronic kidney disease prevalence and ESRD risk. J Am Soc Nephrol 2006; 17: 2275-2284. (Pubitemid 44141918)
13. Otero A, Gayoso P, Garcia F, De Francisco AL: Epidemiology of chronic renal disease in the Galician population: Results of the pilot Spanish EPIRCE study. Kidney Int Suppl 2005; 68:S16-S19.
14. Jong PE, van der Velde M, Gansevoort RT, Zoccali C: Screening for chronic kidney disease: Where does Europe go? Clin J Am Soc Nephrol 2008; 3: 616-623.
15. Otero A, de Francisco ALM, Gayoso P, Garcia F: Prevalence of chronic renal disease in Spain: Results of the EPIRCE study. Nefrologia 2010; 30: 78-86.
16. Coresh J, Selvin E, Stevens LA, et al: Prevalence of chronic kidney disease in the United States. JAMA 2007; 298: 2038-2047. (Pubitemid 350074801)
17. Townsend R, Feldman H: Editorial - chronic kidney disease: Past problems, current challenges, and future facets. NephSAP 2009; 8: 239-243.
18. Educational attainment in the United States: 2003. http://www.census.gov/ prod/2004 pubs/p20-550.pdf.
19. Rodríguez-Pose A, Tselios V: Mapping the European regional educational distribution: Educational attainment and inequality. http://repec.imdea.org/pdf/imdea-wp2007- 18.pdf.
20. CDC: Prevalence of chronic kidney disease and associated risk factors. JAMA 2007; 297: 1767-1768.
21. Iseki K, Ikemiya Y, Kinjo K, Inoue T, Iseki C: Body mass index and the risk of development of end-stage renal disease in a screened cohort. Kidney Int 2004; 65: 1870-1876. (Pubitemid 38591038)
22. Hsu C-Y, McCulloch CE, Iribarren C, Darbinian J, Go AS: Body mass index and risk for end-stage renal disease. Ann Intern Med 2006; 144: 21-28. (Pubitemid 46780716)
23. Chen J, Muntner P, Hamm L, Jones DW, Batuman V, Fonseca V, Whelton P, He J: The metabolic syndrome and chronic kidney disease in US adults. Ann Intern Med 2004; 140: 167-174.
24. Kurella M, Lo JC, Chertow G: Metabolic syndrome and the risk for chronic kidney disease among nondiabetic adults. J Am Soc Nephrol 2005; 16: 2134-2140. (Pubitemid 41716445)
25. CDC - MMWR: Racial/ethnic disparities in prevalence, treatment, and control of hypertension - United States, 1999-2002. http:// www.cdc.gov/mmwr/ preview/mmwrhtml/ mm5401a3.htm.
26. Wolf-Maier K, Cooper ES, Banegas JR, et al: Hypertension prevalence and blood pressure levels in 6 European countries, Canada, and the United States. JAMA 2003; 289: 2363-2369. (Pubitemid 37430168)
27. Cowie CC, Rust KF, Byrd-Holt DD, et al: Prevalence of diabetes and impaired fasting glucose in adults in the US population: National Health and Nutrition Examination Survey 1999-2002. Diabetes Care 2006; 29: 1263-1268. (Pubitemid 44125920)
28. Stock SA, Redaelli M, Wendland G, et al: Diabetes - prevalence and cost of illness in Germany: A study evaluating data from the statutory health insurance in Germany. Diabet Med 2006; 23: 299-305.
29. World Health Organization: Prevalence of overweight and obesity, 2002. World Health Organization, 2005.
30. Ford ES: Prevalence of the metabolic syndrome defined by the International Diabetes Federation among adults in the US. Diabetes Care 2005; 28: 2745-2749. (Pubitemid 43951170)
31. Buckland GG, Salas-Salvado J, Serra-Majem L, Castell C, Cabré J, Salleras-Sanmartí L: Increase in metabolic syndrome as defined by ATPIII from 1992-1993 to 2002-2003 in a Mediterranean population. Nutr Rev 2009; 67:S117-S125.
32. Hallan SI, Vikse BE: Relationship between chronic kidney disease prevalence and endstage renal disease risk. Curr Opin Nephrol Hypertens 2008; 17: 286-291. (Pubitemid 351535932)
33. Al-Aly Z, Zeringue A, Fu J, et al: Rate of kidney function decline associates with mortality. J Am Soc Nephrol 2010; 21: 1961-1969.
34. US Department of Health and Human Services - National Institute of Health: National Diabetes Statistics 2007, NIH publication No. 08-3892, June 2008. www.diabetes.niddk. nih.gov.
35. Obermayr RP, Temml C, Knechtelsdorfer M, et al: Predictors of new-onset decline in kidney function in a general middle-European population. Nephrol Dial Transplant 2008; 23: 1265-1273. (Pubitemid 351767507)